Healthcare Sector Stocks
The Healthcare sector has a total of 1049 stocks, with a combined market cap of $9.14 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 47.21.
Market Cap
9.14T
Revenue
4.67T
Profits
193.51B
PE Ratio
47.21
Profit Margin
4.15%
Dividend Yield
0.40%
1048 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.04T | -1.36% | 1,843,739 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 599.12B | -5.73% | 16,650,526 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 484.83B | -2.40% | 6,409,515 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 350.29B | -2.39% | 8,379,652 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 339.08B | -0.20% | 12,651,791 | 450.06B |
| 6 | NVS | Novartis AG | 272.34B | -0.99% | 1,841,489 | 56.69B |
| 7 | TMO | Thermo Fisher Scientific Inc. | 245.16B | 0.12% | 2,299,319 | 46.34B |
| 8 | AZN | AstraZeneca PLC | 244.42B | -1.59% | 3,112,422 | 61.37B |
| 9 | AMGN | Amgen Inc. | 223.19B | -1.13% | 2,319,588 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 183.41B | -1.67% | 6,234,859 | 30.46B |
| 11 | ABT | Abbott Laboratories | 177.55B | 0.78% | 9,864,566 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 169.97B | -1.35% | 9,261,610 | 50.34B |
| 13 | PFE | Pfizer Inc. | 161.70B | -0.11% | 26,837,188 | 63.70B |
| 14 | DHR | Danaher Corporation | 156.65B | 0.74% | 6,007,549 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 149.10B | -1.30% | 1,739,530 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 122.98B | -4.30% | 1,187,512 | 12.59B |
| 17 | MDT | Medtronic plc | 118.98B | 1.17% | 24,932,054 | 37.54B |
| 18 | BMY | Bristol-Myers Squibb Company | 115.76B | -1.58% | 16,959,364 | 49.19B |
| 19 | MCK | McKesson Corporation | 112.15B | 0.64% | 743,643 | 410.98B |
| 20 | CVS | CVS Health Corporation | 111.97B | -0.22% | 10,479,219 | 412.65B |
| 21 | SYK | Stryker Corporation | 108.38B | -0.02% | 2,072,469 | 25.84B |
| 22 | HCA | HCA Healthcare, Inc. | 99.75B | 0.47% | 1,083,239 | 78.01B |
| 23 | SNY | Sanofi | 94.87B | -1.56% | 3,991,360 | 55.89B |
| 24 | GSK | GSK plc | 93.05B | -1.39% | 5,756,408 | 44.05B |
| 25 | ELV | Elevance Health, Inc. | 92.23B | 0.75% | 1,842,847 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 86.33B | 1.17% | 13,389,343 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 75.20B | -1.27% | 629,546 | 15.53B |
| 28 | CI | The Cigna Group | 74.66B | -0.29% | 1,540,569 | 282.38B |
| 29 | COR | Cencora, Inc. | 62.99B | 1.55% | 1,113,855 | 332.77B |
| 30 | BSX | Boston Scientific Corporation | 62.77B | -1.21% | 14,275,661 | 21.00B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 60.11B | -0.86% | 2,925,076 | 28.42B |
| 32 | NTRA | Natera, Inc. | 57.03B | -0.53% | 1,144,801 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 55.51B | 0.69% | 1,352,296 | 254.25B |
| 34 | BDX | Becton, Dickinson and Company | 51.04B | -0.80% | 1,153,003 | 22.48B |
| 35 | HUM | Humana Inc. | 50.48B | -3.03% | 1,895,866 | 145.68B |
| 36 | ARGX | argenx SE | 50.31B | -1.19% | 277,151 | 5.32B |
| 37 | EW | Edwards Lifesciences Corporation | 49.15B | -1.30% | 3,643,041 | 6.51B |
| 38 | VEEV | Veeva Systems Inc. | 48.84B | 1.95% | 2,253,656 | 3.46B |
| 39 | A | Agilent Technologies, Inc. | 48.38B | 0.16% | 1,536,712 | 7.37B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 48.07B | 0.19% | 6,818,453 | 17.32B |
| 41 | MDLN | Medline Inc. | 46.94B | -0.17% | 4,364,802 | 29.94B |
| 42 | IQV | IQVIA Holdings Inc. | 42.91B | -0.58% | 1,359,675 | 16.98B |
| 43 | WAT | Waters Corporation | 42.17B | -0.68% | 1,066,760 | 4.64B |
| 44 | HLN | Haleon plc | 41.44B | -0.63% | 13,519,881 | 14.80B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 40.99B | -0.69% | 446,338 | 4.55B |
| 46 | ILMN | Illumina, Inc. | 40.95B | -1.99% | 1,898,138 | 4.49B |
| 47 | RVMD | Revolution Medicines, Inc. | 40.39B | -2.84% | 2,941,798 | - |
| 48 | ONC | BeOne Medicines AG | 39.69B | -0.38% | 287,433 | 6.13B |
| 49 | CNC | Centene Corporation | 34.02B | 2.75% | 5,260,823 | 180.30B |
| 50 | BIIB | Biogen Inc. | 33.82B | -0.22% | 1,049,197 | 10.03B |
| 51 | RMD | ResMed Inc. | 33.06B | 0.19% | 892,028 | 5.65B |
| 52 | RPRX | Royalty Pharma plc | 32.53B | -2.09% | 3,582,470 | 2.54B |
| 53 | DXCM | DexCom, Inc. | 32.10B | -1.00% | 4,016,986 | 4.97B |
| 54 | MTD | Mettler-Toledo International Inc. | 32.02B | 2.24% | 245,366 | 4.13B |
| 55 | GEHC | GE HealthCare Technologies Inc. | 31.07B | 1.55% | 3,483,812 | 21.27B |
| 56 | ZTS | Zoetis Inc. | 30.70B | -1.78% | 3,303,088 | 9.53B |
| 57 | ALC | Alcon Inc. | 30.43B | -2.10% | 2,502,987 | 10.86B |
| 58 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.95B | -1.41% | 1,119,028 | 4.80B |
| 59 | WST | West Pharmaceutical Services, Inc. | 26.17B | 1.15% | 507,583 | 3.33B |
| 60 | DGX | Quest Diagnostics Incorporated | 25.44B | -0.93% | 1,010,231 | 11.56B |
| 61 | LH | Labcorp Holdings Inc. | 25.44B | -0.60% | 453,843 | 14.35B |
| 62 | PHG | Koninklijke Philips N.V. | 24.31B | 0.61% | 982,766 | 20.18B |
| 63 | ROIV | Roivant Sciences Ltd. | 24.09B | -3.58% | 6,322,222 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 23.31B | -1.22% | 538,231 | 3.15B |
| 65 | BNTX | BioNTech SE | 22.36B | -7.13% | 1,951,722 | 3.03B |
| 66 | GMAB | Genmab A/S | 22.10B | -2.14% | 3,743,518 | 4.13B |
| 67 | INCY | Incyte Corporation | 22.02B | -2.46% | 2,596,828 | 5.82B |
| 68 | GH | Guardant Health, Inc. | 21.75B | -0.43% | 1,298,970 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 21.49B | -0.69% | 600,002 | 21.81B |
| 70 | STE | STERIS plc | 21.23B | -0.55% | 509,902 | 6.04B |
| 71 | INSM | Insmed Incorporated | 21.14B | -1.80% | 2,162,024 | 1.14B |
| 72 | VTRS | Viatris Inc. | 19.81B | -1.65% | 7,547,575 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.56B | -0.10% | 2,298,439 | 8.51B |
| 74 | RVTY | Revvity, Inc. | 17.30B | -0.34% | 1,387,589 | 2.91B |
| 75 | MEDP | Medpace Holdings, Inc. | 17.02B | -1.64% | 155,256 | 2.78B |
| 76 | EXEL | Exelixis, Inc. | 14.75B | -0.52% | 2,624,725 | 2.44B |
| 77 | SOLV | Solventum Corporation | 14.69B | 1.16% | 985,001 | 8.31B |
| 78 | ASND | Ascendis Pharma A/S | 14.66B | -1.67% | 592,233 | 1.20B |
| 79 | CRL | Charles River Laboratories International, Inc. | 14.27B | -0.94% | 753,332 | 4.00B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 13.74B | -4.41% | 1,568,443 | 3.37B |
| 81 | JAZZ | Jazz Pharmaceuticals plc | 13.66B | -2.93% | 818,017 | 4.60B |
| 82 | BTSG | BrightSpring Health Services, Inc. | 13.05B | -0.57% | 1,411,066 | 14.37B |
| 83 | BAX | Baxter International Inc. | 12.87B | 0.44% | 3,249,507 | 11.47B |
| 84 | CORT | Corcept Therapeutics Incorporated | 12.73B | -2.80% | 556,292 | 830.81M |
| 85 | ICLR | ICON Public Limited Company | 12.68B | -0.04% | 816,545 | 8.29B |
| 86 | PEN | Penumbra, Inc. | 12.61B | -0.30% | 216,895 | 1.50B |
| 87 | HALO | Halozyme Therapeutics, Inc. | 12.44B | -1.31% | 1,780,694 | 1.66B |
| 88 | SMMT | Summit Therapeutics Inc. | 12.41B | -9.40% | 7,131,982 | - |
| 89 | BBIO | BridgeBio Pharma, Inc. | 12.37B | -3.73% | 2,709,110 | 713.07M |
| 90 | TEM | Tempus AI, Inc. | 12.31B | 0.34% | 4,157,827 | 1.43B |
| 91 | EHC | Encompass Health Corporation | 12.27B | -0.07% | 606,746 | 6.21B |
| 92 | SNN | Smith & Nephew plc | 11.69B | 0.69% | 971,839 | 6.30B |
| 93 | DVA | DaVita Inc. | 11.61B | 0.17% | 400,906 | 14.01B |
| 94 | TECH | Bio-Techne Corporation | 11.37B | -0.11% | 2,420,572 | 1.22B |
| 95 | FMS | Fresenius Medical Care AG | 11.24B | -0.61% | 1,071,393 | 22.19B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.20B | -0.66% | 3,345,254 | 5.02B |
| 97 | MOH | Molina Healthcare, Inc. | 10.91B | 2.52% | 1,019,663 | 42.47B |
| 98 | RDY | Dr. Reddy's Laboratories Limited | 10.88B | -0.39% | 2,724,365 | 3.50B |
| 99 | UHS | Universal Health Services, Inc. | 10.55B | 0.10% | 653,664 | 18.11B |
| 100 | BMRN | BioMarin Pharmaceutical Inc. | 10.53B | -1.82% | 2,661,597 | 3.41B |
| 101 | AVTR | Avantor, Inc. | 10.52B | 0.39% | 4,645,932 | 6.56B |
| 102 | PCVX | Vaxcyte, Inc. | 10.51B | -5.45% | 2,814,153 | - |
| 103 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.45B | -3.22% | 315,930 | 1.28B |
| 104 | OSCR | Oscar Health, Inc. | 10.42B | -0.65% | 5,467,552 | 15.32B |
| 105 | IBRX | ImmunityBio, Inc. | 10.39B | -3.16% | 11,620,526 | 165.79M |
| 106 | COO | The Cooper Companies, Inc. | 10.38B | -1.73% | 2,634,043 | 4.24B |
| 107 | GMED | Globus Medical, Inc. | 10.25B | 0.10% | 1,108,139 | 3.14B |
| 108 | ALGN | Align Technology, Inc. | 10.20B | 2.22% | 997,880 | 4.14B |
| 109 | ENSG | The Ensign Group, Inc. | 10.01B | -0.38% | 275,155 | 5.49B |
| 110 | RGEN | Repligen Corporation | 9.90B | 1.69% | 1,259,265 | 785.10M |
| 111 | GKOS | Glaukos Corporation | 9.76B | -1.50% | 909,899 | 612.84M |
| 112 | BIO | Bio-Rad Laboratories, Inc. | 9.73B | -0.19% | 132,592 | 2.59B |
| 113 | PODD | Insulet Corporation | 9.58B | -1.20% | 1,347,395 | 3.05B |
| 114 | KRYS | Krystal Biotech, Inc. | 9.51B | -3.29% | 281,914 | 440.48M |
| 115 | TWST | Twist Bioscience Corporation | 9.49B | -0.35% | 1,529,595 | 431.80M |
| 116 | HSIC | Henry Schein, Inc. | 9.48B | 0.95% | 718,382 | 13.60B |
| 117 | QGEN | Qiagen N.V. | 9.40B | 0.29% | 1,437,226 | 2.10B |
| 118 | TXG | 10x Genomics, Inc. | 9.35B | -4.52% | 4,041,153 | 616.91M |
| 119 | PTGX | Protagonist Therapeutics, Inc. | 8.96B | -4.41% | 1,031,829 | 281.99M |
| 120 | KYMR | Kymera Therapeutics, Inc. | 8.87B | -4.82% | 780,408 | 105.00M |
| 121 | CYTK | Cytokinetics, Incorporated | 8.57B | -1.86% | 1,935,973 | 67.67M |
| 122 | BRKR | Bruker Corporation | 8.56B | -0.11% | 2,171,863 | 3.50B |
| 123 | HNGE | Hinge Health, Inc. | 8.48B | 0.31% | 879,884 | 720.06M |
| 124 | CAI | Caris Life Sciences, Inc. | 8.35B | -0.54% | 3,524,027 | 989.61M |
| 125 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.21B | -4.28% | 2,260,925 | 669.50M |
| 126 | AXSM | Axsome Therapeutics, Inc. | 8.19B | -5.83% | 1,328,732 | 776.57M |
| 127 | TGTX | TG Therapeutics, Inc. | 7.71B | -1.68% | 1,001,270 | 799.54M |
| 128 | ATR | AptarGroup, Inc. | 7.58B | 0.22% | 795,705 | 3.93B |
| 129 | SYRE | Spyre Therapeutics, Inc. | 7.52B | -6.34% | 1,441,085 | - |
| 130 | ABVX | ABIVAX Société Anonyme | 7.51B | -0.83% | 993,314 | 5.33M |
| 131 | HQY | HealthEquity, Inc. | 7.46B | -2.00% | 858,154 | 1.36B |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.04B | -2.95% | 2,983,580 | 874.09M |
| 133 | PACS | PACS Group, Inc. | 7.03B | 0.18% | 554,311 | 5.55B |
| 134 | HIMS | Hims & Hers Health, Inc. | 6.93B | -3.04% | 9,776,812 | 2.58B |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 6.82B | -2.30% | 5,001,278 | 3.12B |
| 136 | PRAX | Praxis Precision Medicines, Inc. | 6.79B | -3.20% | 622,169 | 7.46M |
| 137 | ALKS | Alkermes plc | 6.67B | -1.32% | 1,068,286 | 1.67B |
| 138 | IOVA | Iovance Biotherapeutics, Inc. | 6.57B | -0.41% | 11,923,404 | 324.97M |
| 139 | LNTH | Lantheus Holdings, Inc. | 6.53B | -0.09% | 1,536,473 | 1.56B |
| 140 | GRFS | Grifols, S.A. | 6.52B | -2.71% | 439,636 | 8.48B |
| 141 | CHE | Chemed Corporation | 6.52B | 0.03% | 104,627 | 2.60B |
| 142 | GRAL | GRAIL, Inc. | 6.27B | 2.17% | 703,839 | 165.26M |
| 143 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.13B | -0.90% | 578,479 | 840.85M |
| 144 | BLTE | Belite Bio, Inc | 6.12B | -4.24% | 233,365 | - |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.05B | -2.44% | 203,314 | 290.54M |
| 146 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.96B | -3.57% | 623,191 | 239.92M |
| 147 | IMVT | Immunovant, Inc. | 5.93B | -2.61% | 1,246,834 | - |
| 148 | KOD | Kodiak Sciences Inc. | 5.75B | -7.69% | 1,548,402 | - |
| 149 | BLCO | Bausch + Lomb Corporation | 5.65B | -1.62% | 757,500 | 5.32B |
| 150 | RDNT | RadNet, Inc. | 5.63B | 0.03% | 478,050 | 2.27B |
| 151 | HAE | Haemonetics Corporation | 5.54B | -0.28% | 829,194 | 1.35B |
| 152 | CGON | CG Oncology, Inc. | 5.53B | -1.16% | 1,188,569 | 6.23M |
| 153 | DOCS | Doximity, Inc. | 5.45B | -0.10% | 2,961,621 | 655.57M |
| 154 | TFX | Teleflex Incorporated | 5.27B | -1.00% | 552,384 | 2.25B |
| 155 | MMSI | Merit Medical Systems, Inc. | 5.26B | -1.79% | 842,161 | 1.58B |
| 156 | STVN | Stevanato Group S.p.A. | 5.26B | 0.10% | 398,475 | 1.40B |
| 157 | SHC | Sotera Health Company | 5.20B | 0.33% | 1,647,777 | 1.22B |
| 158 | ORKA | Oruka Therapeutics, Inc. | 5.18B | -2.69% | 503,087 | - |
| 159 | MMED | MiniMed Group, Inc. | 5.18B | -2.13% | 33,807,051 | 3.22B |
| 160 | MIRM | Mirum Pharmaceuticals, Inc. | 5.17B | -7.48% | 762,634 | 618.07M |
| 161 | ERAS | Erasca, Inc. | 5.17B | -4.40% | 5,313,582 | - |
| 162 | WAY | Waystar Holding Corp. | 5.04B | -1.31% | 1,343,081 | 1.21B |
| 163 | PTCT | PTC Therapeutics, Inc. | 5.00B | -4.77% | 1,051,413 | 1.01B |
| 164 | SRRK | Scholar Rock Holding Corporation | 4.93B | -3.39% | 1,096,269 | - |
| 165 | TVTX | Travere Therapeutics, Inc. | 4.88B | -0.42% | 1,668,581 | 591.33M |
| 166 | COGT | Cogent Biosciences, Inc. | 4.88B | -5.67% | 2,995,450 | - |
| 167 | MANE | Veradermics, Incorporated | 4.86B | -5.02% | 845,106 | - |
| 168 | CRSP | CRISPR Therapeutics AG | 4.84B | -2.81% | 1,342,658 | 13.39M |
| 169 | CON | Concentra Group Holdings Parent, Inc. | 4.79B | - | 892,127 | 2.29B |
| 170 | LFST | LifeStance Health Group, Inc. | 4.71B | -1.28% | 1,860,459 | 1.58B |
| 171 | OPCH | Option Care Health, Inc. | 4.66B | - | 5,013,457 | 5.69B |
| 172 | DFTX | Definium Therapeutics, Inc. | 4.62B | -2.33% | 2,000,416 | - |
| 173 | BLLN | BillionToOne, Inc. | 4.46B | 1.47% | 664,221 | 397.41M |
| 174 | HTFL | HeartFlow, Inc. | 4.38B | -0.47% | 1,497,035 | 212.07M |
| 175 | DNTH | Dianthus Therapeutics, Inc. | 4.34B | -4.89% | 1,315,448 | 1.90M |
| 176 | ITGR | Integer Holdings Corporation | 4.30B | 0.06% | 1,710,710 | 1.84B |
| 177 | LIVN | LivaNova PLC | 4.21B | -1.16% | 563,222 | 1.47B |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.18B | -1.77% | 1,937,362 | 1.33B |
| 179 | ABCL | AbCellera Biologics Inc. | 4.09B | -0.24% | 3,254,184 | 66.17M |
| 180 | ICUI | ICU Medical, Inc. | 4.08B | -0.41% | 236,792 | 2.16B |
| 181 | RGC | Regencell Bioscience Holdings Limited | 4.06B | 14.87% | 577,356 | - |
| 182 | ADPT | Adaptive Biotechnologies Corporation | 4.03B | -1.13% | 1,954,780 | 308.08M |
| 183 | EWTX | Edgewise Therapeutics, Inc. | 3.94B | -5.64% | 810,155 | - |
| 184 | RLAY | Relay Therapeutics, Inc. | 3.80B | -3.45% | 1,706,422 | 10.35M |
| 185 | TNGX | Tango Therapeutics, Inc. | 3.75B | -8.07% | 9,619,155 | 53.81M |
| 186 | TLX | Telix Pharmaceuticals Limited | 3.74B | -3.28% | 350,808 | 890.79M |
| 187 | NVST | Envista Holdings Corporation | 3.64B | -0.31% | 2,411,699 | 2.86B |
| 188 | NHC | National HealthCare Corporation | 3.62B | 0.66% | 51,515 | 1.56B |
| 189 | OGN | Organon & Co. | 3.62B | - | 2,893,105 | 6.13B |
| 190 | IRTC | iRhythm Holdings, Inc. | 3.55B | 0.97% | 483,403 | 825.34M |
| 191 | VCYT | Veracyte, Inc. | 3.47B | -2.07% | 760,422 | 561.90M |
| 192 | LEGN | Legend Biotech Corporation | 3.46B | 0.45% | 2,469,108 | 1.27B |
| 193 | PLSE | Pulse Biosciences, Inc. | 3.46B | -7.45% | 455,468 | 1.19M |
| 194 | CDNA | CareDx, Inc. | 3.38B | 3.66% | 1,498,199 | 458.09M |
| 195 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.37B | -2.29% | 1,059,785 | -665.00K |
| 196 | XENE | Xenon Pharmaceuticals Inc. | 3.33B | -3.88% | 1,110,974 | 7.50M |
| 197 | PBLS | Parabilis Medicines, Inc. | 3.32B | -7.25% | 1,187,838 | 148.00K |
| 198 | IDYA | IDEAYA Biosciences, Inc. | 3.31B | -4.99% | 1,027,528 | 234.13M |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 3.28B | -0.50% | 1,888,671 | 463.98M |
| 200 | WRBY | Warby Parker Inc. | 3.28B | 2.04% | 2,838,054 | 911.61M |
| 201 | ACAD | Acadia Pharmaceuticals Inc. | 3.21B | -4.07% | 2,140,647 | 1.14B |
| 202 | VKTX | Viking Therapeutics, Inc. | 3.11B | -5.96% | 5,739,224 | - |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.11B | -4.81% | 1,632,816 | 606.33M |
| 204 | CELC | Celcuity Inc. | 3.09B | -4.04% | 1,497,795 | - |
| 205 | DNLI | Denali Therapeutics Inc. | 2.94B | -2.90% | 1,939,126 | 3.60M |
| 206 | ELVN | Enliven Therapeutics, Inc. | 2.89B | -3.31% | 847,875 | - |
| 207 | ATRC | AtriCure, Inc. | 2.89B | -0.72% | 596,098 | 569.62M |
| 208 | RCUS | Arcus Biosciences, Inc. | 2.87B | -7.52% | 1,393,549 | 117.00M |
| 209 | DYN | Dyne Therapeutics, Inc. | 2.86B | -4.14% | 3,341,605 | - |
| 210 | ACHC | Acadia Healthcare Company, Inc. | 2.81B | 0.50% | 1,269,862 | 3.37B |
| 211 | PRVA | Privia Health Group, Inc. | 2.77B | 0.93% | 1,952,453 | 2.36B |
| 212 | TMDX | TransMedics Group, Inc. | 2.74B | 1.23% | 1,156,245 | 668.47M |
| 213 | PGEN | Precigen, Inc. | 2.68B | -2.35% | 2,403,763 | 85.72M |
| 214 | AVAH | Aveanna Healthcare Holdings Inc. | 2.66B | -0.25% | 1,863,451 | 2.60B |
| 215 | ZLAB | Zai Lab Limited | 2.59B | -6.06% | 778,450 | 449.61M |
| 216 | NEOG | Neogen Corporation | 2.56B | -2.25% | 2,338,562 | 884.00M |
| 217 | CLOV | Clover Health Investments, Corp. | 2.55B | 0.63% | 3,787,639 | 2.48B |
| 218 | GRDN | Guardian Pharmacy Services, Inc. | 2.52B | -1.63% | 300,435 | 1.46B |
| 219 | SLS | SELLAS Life Sciences Group, Inc. | 2.51B | 4.02% | 6,402,123 | - |
| 220 | HCM | HUTCHMED (China) Limited | 2.48B | -1.32% | 37,006 | 549.12M |
| 221 | SUPN | Supernus Pharmaceuticals, Inc. | 2.44B | -1.87% | 1,196,916 | 830.44M |
| 222 | BEAM | Beam Therapeutics Inc. | 2.44B | -2.79% | 1,667,981 | 156.04M |
| 223 | NRIX | Nurix Therapeutics, Inc. | 2.42B | -0.14% | 4,680,864 | 701.94M |
| 224 | BKD | Brookdale Senior Living Inc. | 2.42B | -1.17% | 5,682,196 | 2.93B |
| 225 | NAMS | NewAmsterdam Pharma Company N.V. | 2.41B | -4.99% | 989,724 | 7.12M |
| 226 | LQDA | Liquidia Corporation | 2.40B | -3.11% | 7,653,314 | 450.91M |
| 227 | MBX | MBX Biosciences, Inc. | 2.36B | -5.81% | 769,000 | - |
| 228 | ADMA | ADMA Biologics, Inc. | 2.31B | 1.28% | 3,764,973 | 512.28M |
| 229 | PBH | Prestige Consumer Healthcare Inc. | 2.30B | -1.02% | 494,719 | 1.10B |
| 230 | UFPT | UFP Technologies, Inc. | 2.28B | -0.52% | 100,831 | 631.64M |
| 231 | CLDX | Celldex Therapeutics, Inc. | 2.22B | -4.01% | 1,897,949 | 158.00K |
| 232 | BHC | Bausch Health Companies Inc. | 2.20B | -0.67% | 1,558,343 | 10.85B |
| 233 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | -1.15% | 1,137,741 | 311.51M |
| 234 | IRON | Disc Medicine, Inc. | 2.17B | -6.42% | 603,470 | - |
| 235 | BFLY | Butterfly Network, Inc. | 2.16B | -5.26% | 4,659,666 | 112.14M |
| 236 | HRMY | Harmony Biosciences Holdings, Inc. | 2.16B | -3.14% | 1,420,307 | 959.90M |
| 237 | NEO | NeoGenomics, Inc. | 2.14B | 2.84% | 2,235,748 | 766.30M |
| 238 | PRGO | Perrigo Company plc | 2.13B | -0.52% | 1,761,728 | 4.14B |
| 239 | AXGN | Axogen, Inc. | 2.12B | -2.53% | 2,136,617 | 251.17M |
| 240 | NVAX | Novavax, Inc. | 2.11B | 1.26% | 8,399,432 | 413.80M |
| 241 | MD | Pediatrix Medical Group, Inc. | 2.11B | -1.15% | 461,057 | 1.95B |
| 242 | PHVS | Pharvaris N.V. | 2.11B | -2.82% | 443,982 | - |
| 243 | PGNY | Progyny, Inc. | 2.10B | -2.28% | 1,061,573 | 1.31B |
| 244 | ADUS | Addus HomeCare Corporation | 2.10B | -0.82% | 145,598 | 1.48B |
| 245 | VRDN | Viridian Therapeutics, Inc. | 2.06B | -0.44% | 2,124,102 | 71.13M |
| 246 | VCEL | Vericel Corporation | 2.06B | -0.79% | 511,740 | 306.30M |
| 247 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.06B | -3.47% | 3,043,100 | 940.61M |
| 248 | RXRX | Recursion Pharmaceuticals, Inc. | 2.06B | -4.36% | 19,764,259 | 54.86M |
| 249 | IMNM | Immunome, Inc. | 2.00B | -8.20% | 2,210,604 | 4.02M |
| 250 | INSP | Inspire Medical Systems, Inc. | 1.99B | -3.68% | 1,040,074 | 898.74M |
| 251 | FTRE | Fortrea Holdings Inc. | 1.99B | -0.38% | 767,670 | 2.68B |
| 252 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | -1.50% | 220,986 | 6.13M |
| 253 | TRLV | Trulieve Cannabis Corp. | 1.95B | -2.69% | 902,770 | 1.14B |
| 254 | ASTH | Astrana Health, Inc. | 1.94B | -1.38% | 268,162 | 3.84B |
| 255 | WGS | GeneDx Holdings Corp. | 1.94B | 1.79% | 527,132 | 454.43M |
| 256 | SDGR | Schrödinger, Inc. | 1.94B | -0.08% | 1,302,178 | 259.04M |
| 257 | VERA | Vera Therapeutics, Inc. | 1.93B | -3.35% | 2,990,410 | - |
| 258 | ALVO | Alvotech | 1.92B | -2.18% | 1,214,031 | 494.61M |
| 259 | LKFT | Lakefront Biotherapeutics NV | 1.91B | -1.76% | 175,966 | 1.13B |
| 260 | SGRY | Surgery Partners, Inc. | 1.89B | 2.18% | 1,137,674 | 3.37B |
| 261 | URGN | UroGen Pharma Ltd. | 1.87B | -0.05% | 759,912 | 188.73M |
| 262 | LMAT | LeMaitre Vascular, Inc. | 1.86B | -1.64% | 247,758 | 262.43M |
| 263 | XERS | Xeris Biopharma Holdings, Inc. | 1.86B | -2.49% | 2,220,300 | 335.41M |
| 264 | MLYS | Mineralys Therapeutics, Inc. | 1.86B | -5.53% | 3,346,442 | - |
| 265 | PVLA | Palvella Therapeutics, Inc. | 1.85B | -4.37% | 215,838 | - |
| 266 | MESO | Mesoblast Limited | 1.80B | -2.63% | 260,457 | 120.25M |
| 267 | AGIO | Agios Pharmaceuticals, Inc. | 1.80B | -1.98% | 1,168,644 | 98.34M |
| 268 | VIR | Vir Biotechnology, Inc. | 1.80B | -6.11% | 1,783,882 | 303.23M |
| 269 | ZYME | Zymeworks Inc. | 1.78B | -1.03% | 2,455,340 | 37.13M |
| 270 | TRVI | Trevi Therapeutics, Inc. | 1.75B | -4.95% | 1,576,716 | - |
| 271 | XNCR | Xencor, Inc. | 1.75B | -6.07% | 2,425,957 | 104.97M |
| 272 | SRPT | Sarepta Therapeutics, Inc. | 1.74B | -5.33% | 3,689,044 | 1.97B |
| 273 | ESTA | Establishment Labs Holdings Inc. | 1.74B | -5.16% | 482,984 | 245.82M |
| 274 | BHVN | Biohaven Ltd. | 1.72B | -3.30% | 2,434,063 | - |
| 275 | ALHC | Alignment Healthcare, Inc. | 1.72B | 2.60% | 7,100,903 | 4.58B |
| 276 | SNDA | Sonida Senior Living, Inc. | 1.70B | -0.44% | 413,224 | 481.07M |
| 277 | SEPN | Septerna, Inc. | 1.70B | -3.05% | 491,852 | 98.88M |
| 278 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.70B | -7.51% | 4,326,214 | 208.78M |
| 279 | XRAY | DENTSPLY SIRONA Inc. | 1.70B | -0.29% | 3,981,952 | 3.64B |
| 280 | PSNL | Personalis, Inc. | 1.69B | 0.32% | 3,817,338 | 69.67M |
| 281 | ATEC | Alphatec Holdings, Inc. | 1.67B | -3.82% | 2,322,194 | 815.05M |
| 282 | NTLA | Intellia Therapeutics, Inc. | 1.67B | -5.33% | 5,179,780 | 59.51M |
| 283 | NVCR | NovoCure Limited | 1.67B | -2.85% | 772,628 | 699.19M |
| 284 | OMCL | Omnicell, Inc. | 1.66B | -1.14% | 400,771 | 1.25B |
| 285 | AZTA | Azenta, Inc. | 1.66B | 0.26% | 663,253 | 613.81M |
| 286 | NUVB | Nuvation Bio Inc. | 1.66B | -3.67% | 7,615,685 | 169.90M |
| 287 | ARDT | Ardent Health, Inc. | 1.65B | 1.39% | 630,405 | 6.41B |
| 288 | ZBIO | Zenas BioPharma, Inc. | 1.64B | -4.70% | 519,662 | 1.00M |
| 289 | ALMR | Alamar Biosciences, Inc. | 1.63B | -2.97% | 755,881 | 100.42M |
| 290 | KMTS | Kestra Medical Technologies, Ltd. | 1.61B | 0.22% | 131,777 | 106.73M |
| 291 | GPCR | Structure Therapeutics Inc. | 1.59B | -6.69% | 1,446,141 | - |
| 292 | OCUL | Ocular Therapeutix, Inc. | 1.59B | -4.23% | 3,216,271 | 52.06M |
| 293 | BRVE | Braveheart Bio, Inc. | 1.58B | -5.06% | 212,303 | - |
| 294 | GENB | Generate Biomedicines, Inc. | 1.57B | -11.45% | 964,344 | 26.48M |
| 295 | ABSI | Absci Corporation | 1.56B | -5.89% | 3,047,355 | 1.56M |
| 296 | CMPS | COMPASS Pathways plc | 1.54B | -3.38% | 1,875,024 | - |
| 297 | ETON | Eton Pharmaceuticals, Inc. | 1.52B | -3.48% | 550,948 | 105.60M |
| 298 | ANIP | ANI Pharmaceuticals, Inc. | 1.52B | -3.74% | 331,804 | 978.38M |
| 299 | INVA | Innoviva, Inc. | 1.50B | -3.31% | 811,939 | 440.00M |
| 300 | PAHC | Phibro Animal Health Corporation | 1.49B | -1.66% | 407,386 | 1.52B |
| 301 | MAZE | Maze Therapeutics, Inc. | 1.48B | -3.75% | 615,148 | 20.00M |
| 302 | QURE | uniQure N.V. | 1.48B | -2.56% | 2,490,050 | 18.67M |
| 303 | RARE | Ultragenyx Pharmaceutical Inc. | 1.47B | -2.48% | 5,306,281 | 717.00M |
| 304 | CERT | Certara, Inc. | 1.46B | 3.90% | 2,905,638 | 421.75M |
| 305 | STOK | Stoke Therapeutics, Inc. | 1.45B | -6.83% | 618,021 | 27.59M |
| 306 | PCRX | Pacira BioSciences, Inc. | 1.45B | -0.11% | 2,221,886 | 746.16M |
| 307 | AGL | agilon health, inc. | 1.44B | 0.48% | 153,326 | 5.92B |
| 308 | KRSA | Korsana Biosciences, Inc. | 1.44B | -6.99% | 170,649 | - |
| 309 | HCSG | Healthcare Services Group, Inc. | 1.43B | 1.26% | 673,780 | 1.86B |
| 310 | IMCR | Immunocore Holdings plc | 1.43B | -4.20% | 906,653 | 430.78M |
| 311 | AMN | AMN Healthcare Services, Inc. | 1.42B | 0.72% | 345,958 | 3.43B |
| 312 | PNTG | The Pennant Group, Inc. | 1.40B | -0.91% | 160,597 | 1.10B |
| 313 | NUTX | Nutex Health Inc. | 1.40B | -0.87% | 141,018 | 846.72M |
| 314 | KLRA | Kailera Therapeutics, Inc. | 1.40B | -4.94% | 1,110,006 | - |
| 315 | COAG | Hemab Therapeutics Holdings, Inc. | 1.39B | -1.94% | 441,950 | - |
| 316 | RAPP | Rapport Therapeutics, Inc. | 1.39B | -3.85% | 309,983 | 20.00M |
| 317 | AAPG | Ascentage Pharma Group International | 1.37B | -1.63% | 10,259 | 94.61M |
| 318 | OMER | Omeros Corporation | 1.37B | -3.82% | 994,057 | 38.42M |
| 319 | CNMD | CONMED Corporation | 1.36B | 0.42% | 521,744 | 1.37B |
| 320 | ANAB | AnaptysBio, Inc. | 1.36B | -0.98% | 416,538 | 106.09M |
| 321 | FRNM | Freenome, Inc. | 1.36B | -4.39% | 840,756 | 35.41M |
| 322 | NKTR | Nektar Therapeutics | 1.29B | -4.82% | 2,044,401 | 54.59M |
| 323 | GHRS | GH Research PLC | 1.29B | -5.84% | 426,556 | - |
| 324 | INBX | Inhibrx Biosciences, Inc. | 1.28B | -3.81% | 370,620 | 1.30M |
| 325 | TYRA | Tyra Biosciences, Inc. | 1.28B | -5.31% | 469,541 | - |
| 326 | USPH | U.S. Physical Therapy, Inc. | 1.27B | -0.57% | 104,092 | 804.27M |
| 327 | DRTS | Alpha Tau Medical Ltd. | 1.27B | -3.65% | 484,816 | - |
| 328 | SNDX | Syndax Pharmaceuticals, Inc. | 1.25B | -15.71% | 6,809,602 | 252.25M |
| 329 | INNV | InnovAge Holding Corp. | 1.23B | -1.42% | 460,709 | 989.71M |
| 330 | SVRA | Savara Inc. | 1.21B | -1.24% | 3,742,181 | - |
| 331 | KARD | Kardigan, Inc. | 1.21B | -9.62% | 398,154 | - |
| 332 | CRON | Cronos Group Inc. | 1.18B | -0.31% | 522,867 | 179.09M |
| 333 | GDRX | GoodRx Holdings, Inc. | 1.18B | -0.86% | 736,813 | 785.23M |
| 334 | ORIC | ORIC Pharmaceuticals, Inc. | 1.17B | -4.23% | 1,158,250 | - |
| 335 | TSHA | Taysha Gene Therapies, Inc. | 1.17B | -13.53% | 6,117,196 | 5.49M |
| 336 | AHG | Akso Health Group | 1.16B | -0.80% | 8,889 | 13.83M |
| 337 | TNDM | Tandem Diabetes Care, Inc. | 1.16B | 1.22% | 1,708,696 | 1.04B |
| 338 | BCAX | Bicara Therapeutics Inc. | 1.15B | 0.06% | 1,267,240 | - |
| 339 | IRMD | IRADIMED CORPORATION | 1.15B | 0.20% | 94,743 | 86.34M |
| 340 | DMRA | Damora Therapeutics, Inc. | 1.15B | -8.39% | 285,198 | - |
| 341 | REPL | Replimune Group, Inc. | 1.14B | -7.35% | 1,632,148 | - |
| 342 | BVS | Bioventus Inc. | 1.14B | 0.22% | 335,758 | 581.85M |
| 343 | TRAX | First Tracks Biotherapeutics, Inc. | 1.13B | -6.96% | 1,114,532 | - |
| 344 | VOR | Vor Biopharma Inc. | 1.13B | -3.74% | 949,441 | - |
| 345 | LBRX | LB Pharmaceuticals Inc | 1.12B | -3.17% | 297,406 | - |
| 346 | OMDA | Omada Health, Inc. | 1.12B | -16.32% | 2,843,667 | 309.76M |
| 347 | NBTX | Nanobiotix S.A. | 1.12B | -8.16% | 231,305 | 13.15M |
| 348 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.11B | -2.65% | 326,548 | 730.02M |
| 349 | ENOV | Enovis Corporation | 1.10B | 4.05% | 1,405,755 | 2.30B |
| 350 | PRCT | PROCEPT BioRobotics Corporation | 1.09B | -2.40% | 1,814,716 | 337.34M |
| 351 | TDOC | Teladoc Health, Inc. | 1.09B | 1.35% | 4,280,490 | 2.49B |
| 352 | STAA | STAAR Surgical Company | 1.08B | -2.32% | 446,909 | 339.59M |
| 353 | IART | Integra LifeSciences Holdings Corporation | 1.08B | -0.93% | 823,019 | 1.65B |
| 354 | HROW | Harrow, Inc. | 1.06B | -2.99% | 807,075 | 275.59M |
| 355 | AVLN | Avalyn Pharma Inc. | 1.05B | -4.27% | 403,934 | - |
| 356 | JANX | Janux Therapeutics, Inc. | 1.05B | -5.34% | 795,922 | 24.00M |
| 357 | LTGO | Latigo Biotherapeutics, Inc. | 1.04B | -1.94% | 346,833 | - |
| 358 | AORT | Artivion, Inc. | 1.04B | -1.97% | 664,564 | 471.47M |
| 359 | HSTM | HealthStream, Inc. | 1.03B | 0.87% | 175,270 | 321.12M |
| 360 | LMRI | Lumexa Imaging Holdings, Inc. | 1.02B | -0.66% | 297,628 | 1.04B |
| 361 | CSTL | Castle Biosciences, Inc. | 1.00B | 0.37% | 241,699 | 357.28M |
| 362 | CBLL | CeriBell, Inc. | 1.00B | 3.48% | 542,698 | 101.96M |
| 363 | OPK | OPKO Health, Inc. | 985.15M | -4.35% | 1,558,535 | 587.90M |
| 364 | MNKD | MannKind Corporation | 980.70M | -2.56% | 4,394,242 | 393.63M |
| 365 | QDEL | QuidelOrtho Corporation | 966.91M | 6.42% | 3,053,267 | 2.67B |
| 366 | MGTX | MeiraGTx Holdings plc | 954.67M | -4.24% | 1,122,063 | 397.50M |
| 367 | IMTX | Immatics N.V. | 933.59M | -5.27% | 935,016 | 47.65M |
| 368 | BBNX | Beta Bionics, Inc. | 931.23M | -0.95% | 1,271,752 | 119.01M |
| 369 | AKTS | Aktis Oncology, Inc. | 925.51M | -4.04% | 327,863 | 10.06M |
| 370 | CGEM | Cullinan Therapeutics, Inc. | 907.40M | -5.69% | 590,351 | - |
| 371 | MLTX | MoonLake Immunotherapeutics | 885.96M | -2.53% | 2,412,553 | - |
| 372 | SIBN | SI-BONE, Inc. | 882.03M | -2.09% | 442,588 | 213.60M |
| 373 | RIGL | Rigel Pharmaceuticals, Inc. | 880.57M | -3.42% | 133,999 | 276.79M |
| 374 | KURA | Kura Oncology, Inc. | 874.48M | -5.48% | 2,728,557 | 77.23M |
| 375 | SLBT | SL Science Holding Limited | 872.51M | 1.32% | 121,165 | 3.27M |
| 376 | ANRO | Alto Neuroscience, Inc. | 866.86M | -8.53% | 663,328 | - |
| 377 | SPTX | Seaport Therapeutics, Inc. | 860.77M | -6.24% | 227,203 | - |
| 378 | JBIO | Jade Biosciences, Inc. | 853.48M | -4.14% | 1,331,437 | - |
| 379 | ALMS | Alumis Inc. | 849.10M | -7.08% | 1,899,431 | 7.40M |
| 380 | AHCO | AdaptHealth Corp. | 844.48M | 3.09% | 2,164,066 | 3.36B |
| 381 | GLUE | Monte Rosa Therapeutics, Inc. | 843.75M | -5.99% | 2,716,060 | 28.73M |
| 382 | ODTX | Odyssey Therapeutics, Inc. | 826.11M | -5.59% | 258,820 | 99.00K |
| 383 | GMRS | GMR Solutions Inc. | 823.07M | -0.09% | 823,316 | 5.88B |
| 384 | INMD | InMode Ltd. | 822.26M | 0.03% | 428,626 | 374.63M |
| 385 | ABUS | Arbutus Biopharma Corporation | 813.15M | -0.96% | 3,481,942 | 181.72M |
| 386 | SGP | SpyGlass Pharma, Inc. | 800.08M | -3.78% | 63,852 | - |
| 387 | AVBP | ArriVent BioPharma, Inc. | 793.36M | -2.25% | 1,968,510 | - |
| 388 | DNA | Ginkgo Bioworks Holdings, Inc. | 791.92M | -0.25% | 1,864,100 | 132.42M |
| 389 | CRVS | Corvus Pharmaceuticals, Inc. | 791.58M | -6.37% | 1,685,527 | - |
| 390 | VREX | Varex Imaging Corporation | 778.47M | -0.05% | 149,309 | 865.00M |
| 391 | ARDX | Ardelyx, Inc. | 777.47M | -3.41% | 6,872,759 | 450.89M |
| 392 | GERN | Geron Corporation | 770.97M | -1.64% | 7,591,760 | 204.56M |
| 393 | HELP | Helus Pharma Inc. | 767.13M | -4.81% | 3,180,311 | - |
| 394 | ANL | Adlai Nortye Group Ltd. | 757.00M | -17.33% | 957,736 | 18.06M |
| 395 | APMD | Apnimed, Inc. | 742.28M | -4.29% | 215,572 | 115.12M |
| 396 | OBX | Obsidian Therapeutics, Inc. | 740.66M | -6.25% | 377,260 | - |
| 397 | ANNX | Annexon, Inc. | 726.09M | -3.28% | 3,421,698 | - |
| 398 | SANA | Sana Biotechnology, Inc. | 721.46M | -8.02% | 4,911,407 | - |
| 399 | IMMX | Immix Biopharma, Inc. | 720.43M | -6.05% | 1,485,811 | - |
| 400 | ACHV | Achieve Life Sciences, Inc. | 720.32M | -0.85% | 1,646,074 | - |
| 401 | LXRX | Lexicon Pharmaceuticals, Inc. | 716.38M | -2.42% | 2,051,212 | 41.47M |
| 402 | GYRE | Gyre Therapeutics, Inc. | 711.49M | -2.33% | 85,206 | 109.82M |
| 403 | CADL | Candel Therapeutics, Inc. | 709.33M | -5.21% | 1,133,163 | - |
| 404 | COLL | Collegium Pharmaceutical, Inc. | 700.92M | -2.36% | 846,422 | 808.21M |
| 405 | IVA | Inventiva S.A. | 699.61M | -8.01% | 2,512,970 | 2.81M |
| 406 | CTKB | Cytek Biosciences, Inc. | 695.41M | 0.75% | 1,425,981 | 206.71M |
| 407 | MDXG | MiMedx Group, Inc. | 683.62M | -2.90% | 972,932 | 355.17M |
| 408 | OABI | OmniAb, Inc. | 683.33M | -1.47% | 809,483 | 38.46M |
| 409 | STLN | Starling Oncology, Inc. | 682.84M | -3.18% | 1,277,919 | 587.24M |
| 410 | FDMT | 4D Molecular Therapeutics, Inc. | 682.82M | -4.92% | 991,721 | 92.01M |
| 411 | VSTM | Verastem, Inc. | 674.70M | -9.70% | 3,429,244 | 87.53M |
| 412 | ATTO | Attovia Therapeutics, Inc. | 671.99M | 0.89% | 399,471 | 1.80M |
| 413 | PHAR | Pharming Group N.V. | 669.51M | -1.77% | 28,940 | 366.48M |
| 414 | PHR | Phreesia, Inc. | 667.26M | -0.65% | 508,958 | 507.79M |
| 415 | AURA | Aura Biosciences, Inc. | 650.23M | -4.13% | 1,663,238 | - |
| 416 | AVTX | Avalo Therapeutics, Inc. | 644.10M | -9.29% | 1,649,096 | 59.00K |
| 417 | PACB | Pacific Biosciences of California, Inc. | 637.20M | -2.38% | 12,286,887 | 159.27M |
| 418 | AVR | Anteris Technologies Global Corp. | 628.83M | -3.01% | 764,297 | 2.24M |
| 419 | SLDB | Solid Biosciences Inc. | 624.05M | -13.26% | 2,869,737 | - |
| 420 | WVE | Wave Life Sciences, Inc. | 618.73M | -4.27% | 4,183,602 | 65.37M |
| 421 | ZVRA | Zevra Therapeutics, Inc. | 617.00M | -8.22% | 1,090,679 | 136.07M |
| 422 | OLMA | Olema Pharmaceuticals, Inc. | 614.23M | -4.62% | 2,013,842 | - |
| 423 | DSGN | Design Therapeutics, Inc. | 612.05M | -10.36% | 727,431 | - |
| 424 | SOPH | SOPHiA GENETICS SA | 603.56M | -1.80% | 271,218 | 86.17M |
| 425 | IRWD | Ironwood Pharmaceuticals, Inc. | 593.21M | -4.52% | 2,112,814 | 389.32M |
| 426 | CLYM | Climb Bio, Inc. | 592.17M | -4.80% | 901,344 | - |
| 427 | NVCT | Nuvectis Pharma, Inc. | 591.35M | -7.82% | 215,968 | - |
| 428 | PRME | Prime Medicine, Inc. | 590.64M | -8.03% | 4,064,665 | 4.07M |
| 429 | WEAV | Weave Communications, Inc. | 589.59M | -0.14% | 3,568,757 | 257.79M |
| 430 | AQST | Aquestive Therapeutics, Inc. | 586.14M | -2.91% | 1,400,436 | 54.09M |
| 431 | FLGT | Fulgent Genetics, Inc. | 579.47M | -1.91% | 201,424 | 323.93M |
| 432 | CRMD | CorMedix Inc. | 576.01M | -0.94% | 1,415,670 | 462.25M |
| 433 | KIDS | OrthoPediatrics Corp. | 572.59M | -0.68% | 196,829 | 252.72M |
| 434 | SGMT | Sagimet Biosciences Inc. | 565.85M | -9.32% | 2,524,447 | - |
| 435 | PHAT | Phathom Pharmaceuticals, Inc. | 556.01M | -1.82% | 1,947,160 | 239.66M |
| 436 | FTH | Faeth Therapeutics, Inc. | 555.83M | -7.48% | 350,846 | - |
| 437 | CBIO | Crescent Biopharma, Inc. | 552.56M | -10.72% | 197,107 | 11.88M |
| 438 | STTK | Shattuck Labs, Inc. | 550.99M | -9.85% | 1,576,798 | 1.00M |
| 439 | ETRA | Electra Therapeutics, Inc. | 540.42M | -7.62% | 552,350 | - |
| 440 | DBVT | DBV Technologies S.A. | 540.29M | -5.45% | 344,103 | 5.04M |
| 441 | VALN | Valneva SE | 537.54M | -6.24% | 28,751 | 163.30M |
| 442 | SLN | Silence Therapeutics plc | 534.06M | -8.08% | 1,450,178 | 615.00K |
| 443 | DCTH | Delcath Systems, Inc. | 531.59M | -2.23% | 251,356 | 95.42M |
| 444 | PBYI | Puma Biotechnology, Inc. | 522.40M | -1.65% | 295,845 | 231.24M |
| 445 | EVH | Evolent Health, Inc. | 520.07M | 8.24% | 2,559,082 | 2.10B |
| 446 | DRUG | Bright Minds Biosciences Inc. | 518.46M | -4.91% | 246,572 | - |
| 447 | SSII | SS Innovations International, Inc. | 510.98M | - | 132,747 | 52.40M |
| 448 | ACRS | Aclaris Therapeutics, Inc. | 510.78M | -3.61% | 3,439,350 | 8.22M |
| 449 | CTMX | CytomX Therapeutics, Inc. | 506.62M | -3.93% | 5,223,014 | 18.30M |
| 450 | TCMD | Tactile Systems Technology, Inc. | 505.37M | -1.37% | 155,101 | 350.31M |
| 451 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 452 | MASS | 908 Devices Inc. | 499.72M | 2.28% | 230,405 | 60.84M |
| 453 | EOLS | Evolus, Inc. | 496.04M | -3.10% | 654,414 | 316.49M |
| 454 | BLSM | BlossomHill Therapeutics, Inc. | 492.03M | -10.36% | 118,591 | - |
| 455 | BWAY | BrainsWay Ltd. | 487.82M | 4.01% | 150,794 | 60.70M |
| 456 | EVO | Evotec SE | 486.31M | -1.82% | 113,957 | 819.47M |
| 457 | MNPR | Monopar Therapeutics Inc. | 483.81M | -6.45% | 249,911 | - |
| 458 | RZLT | Rezolute, Inc. | 483.57M | -5.34% | 1,507,764 | - |
| 459 | TLRY | Tilray Brands, Inc. | 479.59M | -2.68% | 4,098,345 | 963.10M |
| 460 | RGNX | REGENXBIO Inc. | 479.26M | -6.56% | 1,378,638 | 174.48M |
| 461 | PROK | ProKidney Corp. | 474.65M | -5.99% | 1,598,948 | 818.00K |
| 462 | ALT | Altimmune, Inc. | 472.68M | -5.08% | 3,715,987 | 31.00K |
| 463 | SENS | Senseonics Holdings, Inc. | 471.64M | -3.46% | 518,688 | 48.55M |
| 464 | OCS | Oculis Holding AG | 470.40M | -3.30% | 320,226 | 1.45M |
| 465 | SGHT | Sight Sciences, Inc. | 462.19M | -6.47% | 413,505 | 83.38M |
| 466 | ANGO | AngioDynamics, Inc. | 458.39M | -4.39% | 1,345,983 | 325.38M |
| 467 | CERS | Cerus Corporation | 455.45M | - | 2,293,133 | 221.55M |
| 468 | KMDA | Kamada Ltd. | 447.25M | -1.91% | 87,329 | 191.85M |
| 469 | ARVN | Arvinas, Inc. | 447.24M | -8.19% | 852,894 | 316.70M |
| 470 | NRC | NRC Health | 446.15M | -1.18% | 58,929 | 140.00M |
| 471 | ALLO | Allogene Therapeutics, Inc. | 445.68M | -7.86% | 6,543,528 | 4.64M |
| 472 | EPRX | Eupraxia Pharmaceuticals Inc. | 444.90M | -8.74% | 1,522,826 | - |
| 473 | TKNO | Alpha Teknova, Inc. | 441.32M | -5.52% | 232,093 | 43.70M |
| 474 | MPLT | MapLight Therapeutics, Inc. | 437.66M | -8.43% | 301,749 | - |
| 475 | NPCE | NeuroPace, Inc. | 435.23M | -2.46% | 66,780 | 106.99M |
| 476 | AGMB | AgomAb Therapeutics NV | 433.87M | -3.08% | 59,376 | - |
| 477 | ENTX | Entera Bio Ltd. | 433.07M | -6.04% | 755,301 | 42.00K |
| 478 | YDES | YD Bio Limited | 432.07M | -3.63% | 23,600 | 1.24M |
| 479 | NGNE | Neurogene Inc. | 431.45M | -11.78% | 442,253 | 925.00K |
| 480 | AUTL | Autolus Therapeutics plc | 431.18M | -6.90% | 2,420,303 | 117.39M |
| 481 | PRTA | Prothena Corporation plc | 429.18M | -0.83% | 573,313 | 54.53M |
| 482 | OVID | Ovid Therapeutics Inc. | 427.70M | -9.13% | 1,642,723 | 1.58M |
| 483 | DMAC | DiaMedica Therapeutics Inc. | 421.70M | -4.63% | 256,052 | - |
| 484 | TECX | Tectonic Therapeutic, Inc. | 416.60M | -4.65% | 164,025 | - |
| 485 | ASMB | Assembly Biosciences, Inc. | 414.13M | -10.67% | 305,630 | 74.85M |
| 486 | RCEL | AVITA Medical, Inc. | 413.18M | -0.07% | 297,579 | 75.63M |
| 487 | ZURA | Zura Bio Limited | 405.36M | 5.75% | 24,435,307 | - |
| 488 | CYH | Community Health Systems, Inc. | 405.23M | 2.40% | 1,853,483 | 11.98B |
| 489 | SPRY | ARS Pharmaceuticals, Inc. | 402.76M | -3.11% | 1,546,825 | 116.93M |
| 490 | CTEV | Claritev Corporation | 401.99M | -2.51% | 121,495 | 994.67M |
| 491 | CAPR | Capricor Therapeutics, Inc. | 400.00M | -7.90% | 2,687,968 | 11.13M |
| 492 | AVIR | Atea Pharmaceuticals, Inc. | 399.42M | -0.99% | 303,227 | - |
| 493 | CARL | Carlsmed, Inc. | 395.07M | -2.10% | 48,431 | 63.30M |
| 494 | AUNA | Auna S.A. | 394.49M | 2.90% | 419,918 | 1.37B |
| 495 | SRTA | Strata Critical Medical, Inc. | 393.68M | -1.98% | 533,680 | 255.98M |
| 496 | MYGN | Myriad Genetics, Inc. | 390.25M | -2.86% | 1,379,442 | 806.60M |
| 497 | OFIX | Orthofix Medical Inc. | 377.18M | -0.22% | 483,733 | 833.19M |
| 498 | SI | Shoulder Innovations, Inc. | 376.20M | -0.88% | 69,130 | 60.06M |
| 499 | EDIT | Editas Medicine, Inc. | 375.50M | -11.09% | 2,453,761 | 47.01M |
| 500 | GALT | Galectin Therapeutics Inc. | 372.14M | -4.65% | 184,925 | - |